1. The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
   Nikola Geskovski et al, 2021, Beilstein Journal of Nanotechnology CrossRef
2. Chitosan–Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy
   Lisa Efriani Puluhulawa et al, 2022, Polymers CrossRef
3. A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network
   Jin Zhang et al, 2022, International Journal of Molecular Sciences CrossRef
4. Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
   Yue Zheng et al, 2022, Frontiers in Oncology CrossRef
5. Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application
   Hongjian Yang et al, 2023, Frontiers in Oncology CrossRef
6. Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain
   Emma Langella et al, 2021, Cellular and Molecular Life Sciences CrossRef
7. CD44: A Multifunctional Mediator of Cancer Progression
   Malak Hassn Mesrati et al, 2021, Biomolecules CrossRef
8. Pleiotropic effects of DCLK1 in cancer and cancer stem cells
   Dibyashree Chhetri et al, 2022, Frontiers in Molecular Biosciences CrossRef
9. Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
   Fatéméh Dubois et al, 2022, Targeted Oncology CrossRef
10. A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
    Mahdi Abdoli Shadbad et al, 2021, Frontiers in Oncology CrossRef
11. The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
    Ting Guo et al, 2022, Frontiers in Oncology CrossRef